120 related articles for article (PubMed ID: 6194783)
21. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
23. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.
Stone M; Bagshawe KD; Kardana A; Searle F; Dent J
Br J Obstet Gynaecol; 1977 May; 84(5):375-9. PubMed ID: 889730
[TBL] [Abstract][Full Text] [Related]
24. Significance of tumour markers in ovarian cancer.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
[No Abstract] [Full Text] [Related]
25. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Irie T; Watanabe H; Kawaoi A; Takeuchi J
Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
[TBL] [Abstract][Full Text] [Related]
26. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
[No Abstract] [Full Text] [Related]
27. Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assay.
Pettersson K; Alfthan H; Stenman UH; Turpeinen U; Suonpää M; Söderholm J; Larsen SO; Nørgaard-Pedersen B
Clin Chem; 1993 Oct; 39(10):2084-9. PubMed ID: 7691439
[TBL] [Abstract][Full Text] [Related]
28. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
29. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
Tanimura T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer.
Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
Eur J Cancer; 1996 Jan; 32A(1):63-8. PubMed ID: 8695243
[TBL] [Abstract][Full Text] [Related]
31. Serial determination of marker substances in ovarian cancer.
Stanhope CR; Smith JP; Britton JC; Crosley PK
Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
[No Abstract] [Full Text] [Related]
32. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
34. Choriocarcinoma: expression of tumor- and trophoblast-associated antigens in patients with low chorionic gonadotropin excretion.
Seppälä M; Rutanen EM; Ranta T; Aho I; Nieminen U; Unnérus HA; Saksela E
Cancer; 1976 Nov; 38(5):2065-70. PubMed ID: 62610
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
Dexeus F; Logothetis C; Hossan E; Samuels ML
J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
[TBL] [Abstract][Full Text] [Related]
36. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
[TBL] [Abstract][Full Text] [Related]
37. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
40. Oncofetal antigens in sacrococcygeal teratomas.
Kuhajda FP; Taxy JB
Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
